COEPTIS Completes $10M Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration February 11, 2025
Aspect Biosystems Closes $115M Series B Financing Round to Advance Bioprinted Tissue Therapeutics February 7, 2025
Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda January 2, 2025
Nuritas Secures $42M Series C to Revolutionize Ingredient Discovery and Improve Lives of Billions December 28, 2024
QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data December 18, 2024
Mana.bio Presents Broad Improvements to Systemic Lipid Nanoparticle Tolerability by Leveraging a Novel AI-Driven Safety Model December 16, 2024
Syncell Announces $15M Series A Funding to Accelerate the Global Commercial Growth of Its Protein Purification and Spatial Proteomics Technology December 14, 2024
Pathos AI Closes $62M Oversubscribed Series C Round of Financing to Accelerate its Platform Approach to Drug Development October 29, 2024
Terray Therapeutics Closes Oversubscribed $120M Series B to Advance Its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic October 20, 2024
COEPTIS Completes $10M Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration February 11, 2025
Aspect Biosystems Closes $115M Series B Financing Round to Advance Bioprinted Tissue Therapeutics February 7, 2025
Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda January 2, 2025
Nuritas Secures $42M Series C to Revolutionize Ingredient Discovery and Improve Lives of Billions December 28, 2024
QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data December 18, 2024
Mana.bio Presents Broad Improvements to Systemic Lipid Nanoparticle Tolerability by Leveraging a Novel AI-Driven Safety Model December 16, 2024
Syncell Announces $15M Series A Funding to Accelerate the Global Commercial Growth of Its Protein Purification and Spatial Proteomics Technology December 14, 2024
Pathos AI Closes $62M Oversubscribed Series C Round of Financing to Accelerate its Platform Approach to Drug Development October 29, 2024
Terray Therapeutics Closes Oversubscribed $120M Series B to Advance Its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic October 20, 2024
